The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management-Reference-Cited by-同舟云学术

The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care management

Published:2019-05-09 Issue:4 Volume:19 Page:383-396
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Jackson Yanina¹,Janssen Ellen²,Fischer Ryan³,Beaverson Katherine⁴,Loftus Jane⁵,Betteridge Kate⁵,Rhoten Stephanie⁶,Flood Emuella²,Lundie Mark⁷

Affiliation:

1. Pfizer Inc, New York, NY, USA

2. ICON plc, Gaithersburg, MD, USA

3. Parent Project Muscular Dystrophy, Hackensack, USA

4. Pfizer Inc, Cambridge, MA

5. Pfizer Ltd, Tadworth, UK

6. ICON plc, South San Francisco, CA, USA

7. Pfizer Canada Inc, Kirkland, Canada

Funder

Pfizer

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2019.1612242

Reference77 articles.

1. Incorporating Patient Preferences into Medical Device Benefit-Risk Assessments

2. Patient Centered Outcomes Research Institute About Us. [Cited 2018 Jul 30]. Available from: https://www.pcori.org/about-us

3. The association between patient activation and accessing online health information: results from a national survey of US adults

4. CMS initiatives to test shared decision making. Medscape medical news. [Cited 2018 Jul 24]. Available from: https://www.medscape.com/viewarticle/873198

5. Patient-Focused Drug Development

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors influencing patient experience in hospital wards: a systematic review;BMC Nursing;2024-08-01

2. Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2);Neurology and Therapy;2024-07-24

3. Patient preferences for preventive migraine treatments among Canadian adults: A discrete choice experiment;Headache: The Journal of Head and Face Pain;2024-07-09

4. Patients’ Preferences for Models of Follow-Up Care During or After Initial Cancer Treatment in Greece: Development of the Qualitative Phase, and Protocol for a Discrete Choice Experiment;European Medical Journal;2024-03-05

5. Exploring Perceptions of Biologic Therapies: A Qualitative Study Among Canadians Living with Severe Asthma;Advances in Therapy;2024-02-13